This content is from: Innovation

PE Firms Eye Glaxosmithkline Portfolio

Glaxosmithkline is seeking to sell its portfolio of consumer products worth £1.5-2 billion.

Glaxosmithkline is seeking to sellitsportfolio of consumer products worth £1.5-2 billion, The Wall Street Journal reports. The potential bidders for the deal include AdventInternational, WarburgPincus and Cinven.

The over-the-counter products, which are primarily sold in Europe and the U.S., created revenues of nearly £500 million in 2010. Goldman Sachs is organizing the auction of the portfolio.

Click here for the story from The Wall Street Journal.

Click here for additional coverage from Reuters.

Related Content